Questioning the Role of HIPEC in Patients with Granulosa Cell Ovarian Tumours
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Zhuang Y, Zhang S, Liu Y, Yang H
. Can adjuvant chemotherapy improve the prognosis of adult ovarian granulosa cell tumors?: A narrative review. Medicine (Baltimore). 2022; 101(11).
PMC: 10513366.
DOI: 10.1097/MD.0000000000029062.
View
2.
Plett H, Ricciardi E, Vacaru V, Ramspott J, Colombo N, Sehouli J
. Adult ovarian granulosa cell tumors: analysis of outcomes and risk factors for recurrence. Int J Gynecol Cancer. 2023; 33(5):734-740.
DOI: 10.1136/ijgc-2022-003854.
View
3.
Celiksoy H, Dickie C, Seckl M, Aydin E, Sozen H, Topuz S
. Effectiveness of adjuvant systemic therapy following complete cytoreductive surgery in patients with recurrent granulosa cell tumours of the ovary. Sci Rep. 2024; 14(1):993.
PMC: 10781791.
DOI: 10.1038/s41598-024-51752-x.
View
4.
Falla-Zuniga L, Sardi A, King M, Lopez-Ramirez F, Barakat P, Nieroda C
. Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). Pleura Peritoneum. 2024; 9(1):15-22.
PMC: 10980981.
DOI: 10.1515/pp-2023-0019.
View